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bstract
This study was designed to determine the neuroprotective potentials of aqueous and methanol extracts from Heinsia  crinita  leaves in vitro.
he total phenol and flavonoid contents of the extracts were determined using colorimetric method while phenolic characterization of the leaf
as analyzed via high performance liquid chromatography-diode array detector (HPLC-DAD). The effects of the extracts on Fe2+-induced lipid
eroxidation in rats’ brain homogenate, monoamine oxidase (MAO), Na+/K+-ATPase, acetylcholinesterase (AChE) and butyrylcholinesterase
BChE) activities were also assessed. The aqueous extract had higher total phenol and flavonoid contents than the methanol extract. HPLC-DAD
evealed that quercetin ellagic, chlorogenic and caffeic acids were the most abundant phenolic compounds in the leaves. The aqueous extract had
igher inhibitory effects on MAO, AChE and BChE activities while there was no significant difference between their Fe2+-induced lipid peroxidation
nhibitory effects. Furthermore, both extracts stimulated Na+/K+-ATPase activity; however, methanol extract had higher stimulatory effect. The
europrotective properties of H.  crinita  leaves could be associated with its inhibitory effects on Fe2+-induced lipid peroxidation and modulation
f MAO, Na+/K+-ATPase, AChE, and BChE activities. Therefore, H.  crinita  leaves could be used as a functional food and dietary intervention for
he management of some neurodegenerative diseases. Nevertheless, the aqueous extracts exhibited better neuroprotective properties.
 2016 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. All rights reserved.
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o.  Introduction
Oxidative stress has been implicated in some neurodegenera-
ive diseases such as Alzheimer’s (AD) and Parkinson’s diseases
PD). Free radical-induced neurodegeneration in brain cells is
sually caused by high levels of polyunsaturated fatty acid, low∗ Corresponding author at: Nutrition and Toxicology Division, Food Technol-
gy Department, Federal Institute of Industrial Research Oshodi, P.M.B. 21023
agos, Nigeria. Tel.: +2347031388644.
E-mail addresses: goboh2001@yahoo.com, goboh@futa.edu.ng (G. Oboh).
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213-4530/© 2016 Beijing Academy of Food Sciences. Production and hosting by Entioxidant capacity, high lipid content of myelin sheaths, high
onsumption of metabolic oxygen and lipid peroxidation in the
ell membrane [1,2]. In addition, elevated levels of reactive oxy-
en species (ROS) can also induce oxidative damage in the nerve
ells which can lead to neuronal injury and radical-induced cell
eath [3].
Furthermore, increase in monoamine oxidase (MAO) activ-
ty has been linked to the excessive production of free radicals,
xidative stress, neuronal injury and hydrolysis of neuro-active
mines such as dopamine, serotonin etc. [4]. However, there are
rowing evidences that the inhibition of MAO activity could
lay a neuroprotective role in some neurodegenerative condi-
ions [5]. Therefore the use of MAO inhibitors could be a good
lsevier B.V. All rights reserved.
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herapeutic strategy in the management/treatment of some neu-
odegenerative conditions such as AD and PD. Furthermore,
everal reports have revealed that decrease in the activities of
holinesterases (AChE and BChE), and stimulation of Na+/K+-
TPase activity relevant to the regulation of neurotransmitters
nd synaptic responses could help to improve cognitive and neu-
onal functions [6,7]. However, increase in AChE and BChE
ctivities could lead to deficits in cholinergic neurotransmitters
n AD patients, while decrease in Na+/K+-ATPase activity can
nduce glutamate neurotoxicity in PD [7–9]. Hence, inhibition of
ChE and BChE activities and stimulation of Na+/K+-ATPase
ctivity could be good therapeutic strategies in the management
nd/or treatment of AD and PD. Interestingly, previous report
as established that cholinesterase inhibitors can also increase
he activity of Na+/K+-ATPase [10].
Vladimir-Kneevic et al. [11] reported that consumption of
edicinal plants can improve cognitive functions in neurode-
enerative conditions. The use of dietary antioxidants and
ioactive compounds from plants and plant extracts has also
een established for the treatment/and or management of some
eurodegenerative diseases. Heinsia  crinita  also known as bush
pple (locally referred to as “atama” in Southern-Nigeria) is
 shrub with dense crown, bisexual flowers and conspicuous
eafy calyx lobes with edible fruits. The leaves are consumed
ither as vegetable in preparation of local cuisine or as compo-
ent of alcoholic concoction for the treatment of some diseases
uch as bacterial infections, diabetes, hypertension and infertility
12,13]. However, to the best of our knowledge, the neuro-
rotective properties of H.  crinita  leaf extracts have not been
eported. Therefore, this study was designed to investigate the
europrotective potentials of aqueous and methanol extracts
rom H.  crinita  leaves via their effects on Fe2+-induced oxida-
ive stress in rats’ brain and enzymes (MAO, AChE, BChE and
a+/K+-ATPase) linked to neurodegenerative diseases such as
lzheimer’s diseases (AD) and Parkinson disease (PD).
.  Materials  and  methods
.1.  Sample  collection
Fresh sample of H.  crinita  leaves was purchased from
kure main market, Akure, Nigeria. The sample was identi-
ed and authenticated at the Department of Biology, Federal
niversity of Technology, Akure, Nigeria by A. A. Sorungbe.
he sample was deposited at the university herbarium with
oucher no FUTA/BIO/135. The leaves were separated from
he stem, air dried at room temperature and pulverized using
aboratory blender. The pulverized sample was sieved in Wil-
ey 60 mesh size and stored in the refrigerator. The powder
as analyzed via HPLC-DAD. Unless stated otherwise, all
ther chemicals and reagents used were of analytical grades
nd the water was glass distilled. Kenxin (Model KX3400C)
efrigerated centrifuge was used while JENWAY UV-visible
pectrophotometer (Model 6305; Jenway, Barlo World Sci-
ntific, Dunmow, United Kingdom) was used to measure
bsorbance.
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.2.  Preparation  of  extracts
The methanol and aqueous extracts were prepared by mac-
rating 5 g of the powdered sample in 100 mL of absolute
ethanol and distilled water for 16 h respectively. The extracts
ere filtered (filter paper Whatman No. 2) and centrifuged at
000 rev/min for 10 min to obtain clear supernatant. Supernatant
rom the methanol extract was evaporated under a vacuum at
5 ◦C until about 90% of the filtrate was evaporated. There-
fter, both samples were lyophilized to obtain dry extracts which
ere kept in the refrigerator (≤4 ◦C) in sealed vials for further
nalysis.
.3.  Determination  of  total  phenol  content
The total phenol content was determined according to the
ethod described by Singleton et al. [14]. Briefly, diluted
xtract were oxidized with 2.5 mL of 10% Folin–Ciocalteau’s
eagent (v/v) and neutralized with 2.0 mL of 7.5% sodium car-
onate. The mixture was incubated for 40 min at 45 ◦C and
he absorbance was measured at 765 nm using UV–visible
pectrophotometer. The total phenol content was subsequently
alculated using gallic acid as standard and expressed as gallic
cid equivalent (GAE) based on the dry weight of the sample.
.4.  Determination  of  total  ﬂavonoid  content
The total flavonoid content was determined using a slightly
odified method reported by Meda et al. [15]. Briefly, 0.5 mL
f the extracts were mixed with 0.5 mL of absolute methanol,
0 L of 10% AlCl3, 50 L of 1 mol/L potassium acetate, and
.4 mL of distilled water. The solution was incubated at room
emperature for 30 min. The absorbance of the reaction mixture
as subsequently measured at 415 nm. The total flavonoid con-
ent was calculated using quercetin as standard and expressed
s quercetin equivalent (QE) based on the dry weight of the
amples.
.5.  Quantiﬁcation  of  phenolic  compounds  by  HPLC-DAD
Reverse phase chromatography analyses were carried out
nder gradient conditions using 1% formic acid and acetoni-
rile as the mobile phase and C18 column (4.6 mm ×  150 mm)
s the stationary phase. A composition gradient of 13% ace-
onitrile was run for 10 min. The composition gradient was
ubsequently increased and varied with respect to time as
escribed by Adedayo et al. [16] with slight modifications. The
owder that was obtained from H.  crinita  leaves and the mobile
hase were filtered through 0.45 m membrane filter (Milli-
ore) and then degassed by ultrasonic bath prior to use. The
xtract was analyzed at a concentration of 20 mg/mL. The flow
ate was set at 0.6 mL/min while the injection volume used for
he analysis was 40 L. Appropriate wavelengths were used
o determine gallic acid (254 nm), catechin (280 nm), epicate-
hin (280 nm), chlorogenic acid (325 nm), caffeic acid (325 nm),
llagic acid (325 nm), quercetin (365 nm), quercitrin (365 nm),
utin (365 nm) and kaempferol (365 nm). Stock solutions of
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eference standards for the flavonoids (0.030–0.250 mg/mL) and
henolic acids (0.050–0.450 mg/mL) were prepared using the
obile phase. Chromatographic peaks were confirmed by com-
aring the retention time of the samples with reference standards
y DAD spectra (200–500 nm). All chromatographic operations
ere carried out at ambient temperature and in triplicates. The
imit of detection (LOD) and limit of quantification (LOQ) were
alculated based on the standard deviation of the responses and
he slope using three independent analytical curves. LOD and
OQ were calculated as 3.3 and 10 σ/S, respectively, where σ  is
he standard deviation of the response and S is the slope of the
alibration curve [17].
.6.  Handling  of  experimental  animals
Adult male wistar strain albino rats (weighing between 180
nd 210 g) were purchased from the animal breeding colony of
nimal Production and Health Department, Federal University
f Technology, Akure. Handling of the animals was in accor-
ance with the Guide for Care and Use of Laboratory Animals
repared by the National Academy of Science which was pub-
ished by the National Institute of Health (USA) [18]. The rats
ere allowed to acclimatize for 14 days and maintained at room
emperature under laboratory conditions with access to standard
nimal feed and water ad libitum.
.7.  Lipid  peroxidation  assay
The rat was decapitated under mild anesthesia (diethyl ether)
nd the brain tissue was isolated and placed on ice and weighed.
he tissue was subsequently homogenized in cold saline (1/10,
/v) with about 10-up and -down strokes at approximately
200 rev/min in a Teflon glass homogenizer. The homogenate
as centrifuged for 10 min at 3000 ×  g. The pellets obtained
ere discarded while the supernatant was kept for lipid per-
xidation assay [19]. One hundred microliter (100 L) of the
upernatant was mixed with a reaction mixture containing 30 L
f 0.1 mol/L Tris–HCl buffer (pH 7.4), different concentra-
ions of extract and 30 L of freshly prepared FeSO4 solution
250 mol/L). The volume was made up to 300 L with dis-
illed water before incubation at 37 ◦C for 1 h. The chromogen
as developed by adding 300 L of 8.1% sodium dodecyl sul-
hate (SDS), 600 L of acetic acid/HCl mixture (pH 3.4) and
00 L of 0.8% TBA. The reaction mixture was incubated at
00 ◦C for 1 h. The TBARS produced was measured at 532 nm
20] and calculated as the percent of MDA (Malondialdehyde)
roduced (% Control) using the MDA standard curve.
.8.  Enzyme  inhibition  assay
.8.1.  Monoamine  oxidase  (MAO)  inhibition  assay
Different concentrations of the extracts were prepared
ccording to the methods of Green and Haughton [21] and
urski et al. [22], with slight modification. The reaction mixture
ontained 0.025 mol/L phosphate buffer of pH 7, 0.0125 mol/L
emicarbazide, 10 mmol/L benzylamine (pH 7), 0.67 mg of
nzyme and extract in a total reaction volume of 2 mL. After
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0 min, 1 mL of acetic acid was added and boiled for 3 min and
hen centrifuged. The resultant supernatant (1 mL) was mixed
ith equal volume of 0.05% 2, 4-DNPH and 2.5 mL of absolute
enzene. The resultant solution was incubated at room temper-
ture for 10 min. After the incubation, the benzene layer was
solated and mixed with equal volume of 0.1 N NaOH. Alka-
ine layer was decanted and heated at 80 ◦C for 10 min. The
range-yellow color formed was measured at 450 nm.
.8.2. Na+/K+-ATPase  activity  assay
The Na+/K+-ATPase activity was measured according to the
ethod described by Wyse et al. [23]. The assay mixture consist
f 50 L of Na+/K+-ATPase substrate buffer (pH 7.4) contain-
ng 30 mmol/L of Tris–HCl, 0.1 mmol/L of EDTA, 50 mmol/L
f NaCl, 5 mmol/L of KCl, and 6 mmol/L of MgCl2 (pH 7.4),
xtract (50 L) and 50 L of supernatant in the presence or
bsence of 50 L of 1 mmol/L ouabain in a final volume of
00 L. The reaction was initiated by the addition of 50 L
TP to a final concentration of 3 mmol/L. After incubation for
0 min at 37 ◦C, the reaction was terminated by the addition of
0 L of 50% (w/v) trichloroacetic acid (TCA). The amount of
norganic phosphate (Pi) released was quantified as described
y Fiske and Subbarow [24] using a reaction mixture that con-
ained 100 L of ammonium molybdate (50 mmol/L), 40 L
f reaction mixture from first grid and 10 L of ascorbic acid
8%). Different concentrations (0, 4, 8, 10, 20, 40 nmol/L) of
aH2PO4 (1 mmol/L) were used to make a calibration curve
f inorganic phosphate. Specific Na+/K+-ATPase activity was
alculated by subtracting the ouabain-insensitive activity from
he overall activity (in the absence of ouabain) and expressed in
mol of Pi/mg of protein/min.
.8.3.  Acetylcholinesterase  inhibition  assay
The AChE inhibitory ability of the extracts was assessed
y a modified colorimetric method of Perry et al. [25]. The
ChE activity was determined in a reaction mixture contain-
ng 200 L of AChE solution (EC 3.1.1.7, 0.1 mol/L phosphate
uffer pH 8.0), 100 L of 5,5′-dithio-bis(2-nitrobenzoic) acid
DTNB 3.3 mmol/L), different concentration (0–100 L) of the
xtract and 500 L of phosphate buffer (pH 8.0). After incu-
ation for 20 min at 25 ◦C, acetylthiocholine iodide (100 L of
.05 mmol/L solution) was added as the substrate, and AChE
ctivity was determined from the changes in absorbance at
12 nm which was read for 3 min at room temperature. The
ChE inhibitory activity was expressed as percentage inhibition.
.8.4.  Butyrylcholinesterase  (BChE)  inhibition  assay
Inhibition of BChE was assessed by a modified colorimetric
ethod of Ellman et al. [26]. The BChE activity was deter-
ined in a reaction mixture containing 200 L of BChE solution
0.415 U/mL in 0.1 mol/L phosphate buffer, pH 8.0), 100 L
f a solution of 5,5′-dithiobis(2-nitrobenzoic) acid (3.3 mmol/L
n 0.1 mol/L phosphate-buffered solution, pH 7.0) containing
aHCO3 (6 mmol/L), extract (0–100 L), and 500 L of phos-
hate buffer, pH 8.0. After incubation for 20 min at 25 ◦C,
utyrylthiocholine iodide (100 L of 0.05 mmol/L solution) was
dded as the substrate, and BChE activity was determined from
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Table 1
The total phenol and flavonoid contents and EC50 values of modulation of Fe2+-
induced MDA production, MAO, Na+/K+ ATPase, AChE and BChE activities
of Heinsia crinita leaves extracts.
Parameter (unit) Aqueous extract Methanol extract
Total phenol content (mg GAE/g) 8.77 ± 0.20a 5.51 ± 0.09b
Total flavonoid content (mg QE/g) 14.47 ± 1.29a 5.57 ± 0.21b
Fe2+-induced lipid peroxidation (mg/mL) 3.06 ± 0.04a 3.01 ± 0.03a
Monoamine oxidase (mg/mL) 4.03 ± 0.07a 6.76 ± 0.05b
Na+/K+ ATPase (mg/mL) 4.05 ± 0.05a 3.33 ± 0.03b
Acetylcholinesterase (mg/mL) 32.11 ± 0.12a 33.67 ± 0.22b
Butyrylcholinesterase (mg/mL) 30.4 ± 0.52a 32.95 ± 0.43b
Values represent means of triplicate readings. Values with same superscripts are
not significantly different at P > 0.05.
Table 2
Phenolic acid and flavonoid composition of Heinsia crinita leaves.
Parameter mg/g %
Gallic acid 43.51 ± 0.03 4.35
Catechin 9.46 ± 0.01 0.09
Chlorogenic acid 72.90 ± 0.01 7.29
Caffeic acid 80.51 ± 0.02 8.05
Ellagic acid 116.74 ± 0.01 11.61
Epicatechin 64.39 ± 0.03 6.43
Rutin 54.27 ± 0.02 5.42
Quercitrin 39.15 ± 0.01 3.91
Quercetin 44.26 ± 0.02 4.43
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Fig. 1. Representative high performance liquid chromatography profile of pow-
dered Heinsia crinita. Gallic acid (peak 1), catechin (peak 2), chlorogenic acid
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taempferol 7.52 ± 0.03 0.57
alues represent means ± standard deviation of triplicate readings.
he changes in absorbance at 412 nm which was read for 3 min
t room temperature.
.9.  Data  analysis
The results of triplicate readings of the experiments were
xpressed as mean ±  standard deviation (SD). One-way analy-
is of variance (ANOVA) was used to analyze the mean and the
ost hoc treatment was performed using Duncan multiple test.
ignificance was accepted at P  ≤  0.05. EC50 (extract concentra-
ion causing 50% enzyme/antioxidant activity) was determined
sing non-linear regression analysis.
.  Results  and  discussion
.1.  Phenolic  composition
The results of total phenol and flavonoid contents of the
xtracts presented in Table 1 showed that the aqueous extract had
igher total phenol (8.77 mg GAE/g) and flavonoid (14.47 mg
E/g) contents than methanol extract (total phenol = 5.51 mg
AE/g; total flavonoid = 5.57 mg QE/g). Furthermore, the phe-
olic characterization of H.  crinita  leaves revealed the presence
f gallic acid (43.51 mg/g), catechin (9.46 mg/g), chloro-
enic acid (72.90 mg/g), caffeic acid (80.51 mg/g), ellagic acid
116.74 mg/g), epicatechin (64.39 mg/g), rutin (54.27 mg/g),
uercitrin (39.15 mg/g), quercetin (44.26 mg/g) and kaempferol
7.52 mg/g) (Fig. 1 and Table 2).
p
d
opeak 3), caffeic acid (peak 4), ellagic acid (peak 5), epicatechin (peak 6), rutin
peak 7), quercitrin (peak 8), quercetin (peak 9) and kaempferol (peak 10).
.2.  Inhibition  of  malondialdehyde  production
The ability of the extracts to inhibit Fe2+-induced lipid per-
xidation in rats’ brain homogenate is presented in Fig. 2. The
esult revealed that Fe2+ caused a significant increase in MDA
ontent in the rats’ brain. However, the addition of the extracts
n a dose-dependent manner (0.78–3.5 mg/mL) caused a signif-
cant decrease in MDA levels (aqueous extract = 67.9–61.1%;
ethanol extract = 50.0–79.8%). Our findings revealed that the
xtracts were able to inhibit the production of MDA in rats’ brain.
DA is a toxic chemical capable of causing oxidative damage
o the brain cells and has been implicated in the pathogenesis
nd progression of some neurodegenerative conditions such as
D and PD [27]. Previous studies have shown that Fe accumu-
ates in the brain of AD patients and animal models. Moreover
e can initiate Fenton reaction which could lead to the produc-
ion of OH radicals [28]. These radicals are capable of inducing
xidative stress/damage to membrane lipids, DNA, proteins and
ther electron rich biomolecules. The inhibition of Fe2+-induced
ipid peroxidation by the extracts from H.  crinita  leaves agrees
ith previous studies on plant extracts [29]. However, there
as no significant (P  > 0.05) difference between the Fe-induced
nhibitory abilities of aqueous and methanol extracts.
.3.  Inhibition  of  enzymes  linked  to  some
eurodegenerative  diseases
The effects of the extracts on MAO, Na+/K+-ATPase, AChE
nd BChE activities are presented in Figs. 3–6 respectively
ith their EC50 values in Table 1. The extracts were able
o modulate enzyme activities in a dose dependent manner.
he aqueous extract (4.03 mg/mL) had higher MAO inhibitory
ctivity than the methanol extract (6.79 mg/mL). The inhibi-
ion of MAO activity by the extracts indicates their therapeutic
otential in the treatment/management of AD and PD. The
ecrease in MAO activity could consequently, increase the level
f amine neurotransmitters such as dopamine and serotonin
G. Oboh et al. / Food Science and Human Wellness 5 (2016) 95–102 99
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Fig. 2. Inhibition of Fe2+ induced lipid peroxidation in rat brain by aqueous and methanolic extract from Heinsia crinita leaves. Values represent mean ± standard
deviation (n = 3).
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Fig. 5. Inhibition of acetylcholinesterase activity by aqueous and methanolic extract from Heinsia crinita leaves. Values represent mean ± standard deviation (n = 3).
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Furthermore, the effects of the extracts on Na+/K+-ATPase
ctivity revealed that there was an increase in the activity
f the enzyme. The methanol extract (13.2–44.6%) had bet-
er Na+/K+-ATPase stimulatory ability compared to aqueous
xtract (5.7–41.5%). Increase in Na+/K+-ATPase activity is
n important therapeutic target in the management of some
eurodegenerative diseases [33,34]. This is because Na+/K+-
TPase is required for memory function, neuronal-ion balance
nd transmission of messages in the synaptic cleft. Reduction
f Na+/K+-ATPase activity could lead to cognitive impairment
nd neuronal damage characterized by necrosis and apoptosis
35]. Several reports have indicated decrease in Na+/K+-ATPase
ctivity in some neurological disorders such as AD, epilepsy,
epression and cerebral ischemia [10,36]. In this study, the
xtracts stimulated Na+/K+-ATPase activity which could be due
o their phenolic constituents. This result agrees with that of
ubash et al. [37], that pomegranate improved Na+/K+-ATPase
ctivity. Furthermore, Javorková et al. [38] reported that there
s a relationship between polyphenols and increase in Na+/K+-
TPase activity. Moreover flavonoids such as quercetin and
utin have previously been reported to be potent modulators
f Na+/K+-ATPase activity [37,39]. It is important to note that
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Htration (mg/mL)
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xidative stress caused by overproduction of ROS could reduce
he activity of Na+/K+-ATPase [40] which consequently affects
he depolarization of neurons and induce oxidative damage to
he nerve cells [41]. Therefore, the ability of the extracts to stim-
late Na+/K+-ATPase activity and inhibit lipid peroxidation in
solated rat brain tissue homogenate could be of great therapeu-
ic importance in the management of several neurodegenerative
iseases.
The AChE inhibitory activity of the extracts revealed that the
queous extract had higher inhibitory effect (32.11 mg/mL) than
ethanol extract (33.67 mg/mL). Similarly, the aqueous extract
30.4 mg/mL) also had higher inhibitory effect on BChE activ-
ty than the methanol extract (32.95 mg/mL). Cholinesterases
AChE and BChE) catalyze the rapid breakdown of acetyl-
holine (ACh) and butyrylcholine (BCh) into acetate and
holine. Moreover, this could lead to cholinergic deficit and cog-
itive impairment. Hence, inhibition of cholinesterases could be
 good therapeutic target for the treatment and management of
D as it can increase the concentration of ACh and BCh inhe synaptic cleft and consequently improve communications
etween nerve cells in the brain [42]. Our findings revealed that
. crinita  leave extracts had inhibitory effects on AChE and
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ChE activities which is consistent with earlier studies on some
ruits and vegetables [37,43]. In addition, inhibition of BChE
ctivity is therapeutically important in the management of AD;
ncrease in BChE activity could lead to increase in the production
f neurotoxic plaques which is a risk factor in the pathogenesis
f AD [44–46]. The aqueous extract had higher inhibitory effects
han methanol extract and this could be due to the higher total
henol and flavonoid contents that was observed in the aqueous
xtract. Phenolic acids and flavonoids are known to have struc-
ural similarities with synthetic cholinesterase inhibitors such
s donepezil, rivastigmine and prostigmine [47,48]. Moreover,
olecular docking studies have shown that flavonoids such as
uercetin, quercitrin, rutin and kaempferol which were iden-
ified in H.  crinita  leaves have aromatic rings (B-rings) and
ydroxyl groups that could bind to the peripheral anionic site
f cholinesterases thereby blocking the natural substrate from
inding to the site [47–49]. Furthermore, according to the report
f Roseiroa et al. [48], the methoxyl groups of caffeic acid could
ind to the tryptophan residue on the active site of the enzyme
hereby reducing its activity. Interestingly, several reports have
hown that dietary polyphenols can cross blood–brain barrier,
ither in their natural form or as metabolites [50,51].
.  Conclusion
This study revealed that aqueous and methanol extracts from
. crinita  leaves modulates the activities of enzymes (MOA,
ChE, BChE and Na+/K+-ATPase) linked to neurodegenera-
ive diseases, as well as inhibit Fe2+-induced lipid peroxidation
n isolated rat brain; these biological activities could be part
f the possible mechanisms by which the extracts exert their
europrotective abilities and could be linked to their pheno-
ic constituents. However, the aqueous extract showed higher
europrotective properties than the methanol extract. These find-
ngs have given a clue on the dietary and medicinal importance
f H.  crinita  leaves as an alternative/complementary therapy
or the treatment/management of neurodegenerative diseases.
evertheless, further in  vivo  and clinical experiments are rec-
mmended.
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